Tag:
Hikma
Latest Headlines
Latest Headlines
UPDATED: Hikma remediation to cost it generic sales
Jordan-based Hikma Pharmaceuticals ($HIK), which has indicated that it has big plans to grow, says it received an FDA warning letter for its plant in Eatontown, NJ.
Hikma to plow $300M into M&A, internal growth
Hikma Pharmaceuticals may not be a Big Pharma, but it has big pharma plans.
West-Ward hit with FDA warning letter over manufacturing, testing problems
The FDA has told West-Ward Pharmaceuticals it needs to fix manufacturing and testing issues that have permitted the release of lithium and digoxin tablets that fail size specifications. The Feb. 3...
Hikma moves into Morocco with $111M deal
Jordan's Hikma Pharmaceuticals has made its first foray into Morocco with a $111 million deal for controlling interest in Promopharm, the country's 9th-largest drugmaker with 200 branded generics and
Hikma expects boost in Middle East health spending
Hikma sales suffered during the first half of this year, partly because of unrest in the Arab world. But that very unrest will end up lifting healthcare spending, the Jordanian company's Middle East
GSK leads pharma charge to Middle East
The pharma manufacturing base has now spread to Iraq. Expansion-minded GlaxoSmithKline ( $GSK ), which has been supplying the Iraqi market for two decades, is now setting up a production operation
N. American pharma buys drive up M&A prices
European drugmakers have more competition for nearby buyouts these days. With North America's pharma companies turning to international markets for growth, they're scouting Central Europe, Eastern
Drugmakers rack up $1B in small deals
Drugmakers may be focusing on smaller deals this year, rather than the megamergers of 2009, but those smaller buys do add up. In fact, over the past 24 hours, three drug-company buyouts were
